Reply Considerations When Evaluating Cost-Effectiveness Analyses of Novel Stroke Prevention Therapies

We appreciate the thorough review of our paper (1) by Drs. Singh and Wijeysundera and wish to clarify our analysis based upon their feedback.

Source: Journal of the American College of Cardiology - May 3, 2016 Category: Cardiology Source Type: research